Sharda Cropchem intangible spending reaches Rs 418.83 crore

Sharda Cropchem Limited spent Rs 418.83 crore on intangible assets, including assets under development and capital advances, in the half year ended September 30, 2026, compared with Rs 252.82 crore a year earlier. The outlay rose Rs 166.01 crore, while reported intangible-asset balances increased Rs 129.58 crore from March 31, 2026.

How much did Sharda Cropchem spend on intangible assets?

Sharda Cropchem spent Rs 418.83 crore on purchases of intangible assets, including intangible assets under development and capital advances, in the half year ended September 30, 2026. The expenditure was Rs 252.82 crore in the half year ended September 30, 2025, making the year-on-year increase Rs 166.01 crore.

The purchase line was the largest individual cash outflow reported within investing activities in the September 2026 half year. It was larger than the group's Rs 405.76 crore net cash used in investing activities because that section also included proceeds and purchases involving mutual funds, bonds, bank deposits and interest receipts.

Purchases of property, plant and equipment, including capital work in progress, were Rs 4.23 lakh in the September 2026 half year, compared with Rs 47.02 lakh in the corresponding 2025 period. The contrast places the disclosed investment cash outflow primarily in the intangible-assets line rather than physical assets.

What changed in Sharda Cropchem's intangible-asset balances?

Sharda Cropchem reported other intangible assets of Rs 1,059.28 crore at September 30, 2026, up from Rs 986.22 crore at March 31, 2026. Intangible assets under development rose to Rs 303.76 crore from Rs 247.24 crore over the same six-month period.

Together, the two balance-sheet categories totalled Rs 1,363.04 crore at September 30, 2026, against Rs 1,233.46 crore at March 31, 2026. The combined increase was Rs 129.58 crore, comprising a Rs 73.06 crore rise in other intangible assets and a Rs 56.53 crore increase in assets under development.

The balance increase was below the Rs 418.83 crore cash-purchase line. The filing reports Rs 200.63 crore of consolidated depreciation and amortisation expense in the half year, compared with Rs 154.25 crore a year earlier, and Rs 11.26 crore of discards or write-offs of intangible assets and assets under development, versus Rs 29.00 crore in the prior-year period. It does not provide a category-by-category reconciliation from cash purchases to closing intangible balances.

How did intangible spending affect Sharda Cropchem's cash flows?

Sharda Cropchem generated Rs 564.20 crore of net cash from operating activities in the half year ended September 30, 2026, compared with Rs 605.14 crore in the comparable 2025 half year. Operating cash flow declined Rs 40.94 crore while purchases of intangible assets increased Rs 166.01 crore.

The operating cash flow included a Rs 876.65 crore decrease in trade receivables, compared with a Rs 764.54 crore decrease in the prior-year half year. Inventories increased by Rs 409.39 crore in the September 2026 half year, versus an increase of Rs 446.99 crore a year earlier.

Cash and cash equivalents increased Rs 85.19 crore during the September 2026 half year to Rs 299.01 crore. Net financing cash outflow was Rs 88.15 crore, including Rs 81.18 crore of dividend payments on equity shares, compared with Rs 54.64 crore of dividend payments in the previous corresponding period.

Which operating results accompanied Sharda Cropchem's outlay?

Sharda Cropchem reported consolidated revenue from operations of Rs 2,125.45 crore for the half year ended September 30, 2026, compared with Rs 1,913.93 crore a year earlier. Agrochemicals generated Rs 1,754.58 crore of revenue, up from Rs 1,648.98 crore, while non-agrochemicals generated Rs 370.87 crore, up from Rs 264.95 crore.

Profit before tax declined to Rs 225.91 crore from Rs 254.86 crore, and net profit decreased to Rs 179.74 crore from Rs 217.15 crore. Agrochemicals segment results fell to Rs 151.18 crore from Rs 170.44 crore, whereas non-agrochemicals segment results increased to Rs 73.45 crore from Rs 71.93 crore.

The group identifies agrochemicals as a seasonal business whose performance can be affected by cropping patterns and weather conditions across global markets. At September 30, 2026, total assets were Rs 5,659.13 crore, down from Rs 5,780.30 crore at March 31, 2026, despite the increase in intangible-asset balances.

What do Sharda Cropchem's disclosures say about funding and review?

Sharda Cropchem's cash-flow statement reports Rs 564.20 crore of operating cash inflow and no borrowing inflow within financing activities for the September 2026 half year. Finance costs were Rs 2.71 crore, compared with Rs 89.93 lakh in the corresponding 2025 half year.

The balance sheet reported lease liabilities of Rs 24.23 crore at September 30, 2026, comprising Rs 15.15 crore of non-current liabilities and Rs 9.08 crore of current liabilities. No lease-liability balance was presented at March 31, 2026 in the comparative statement.

The board approved the unaudited consolidated results on October 30, 2026 after Audit Committee review, and the statutory auditors expressed an unmodified conclusion. The filing covered a group with 36 subsidiaries, including eight step-down subsidiaries of one subsidiary, as at September 30, 2026.

Conclusion

Sharda Cropchem's September 2026 half-year filing shows that intangible assets were a major investing use of cash, with purchases rising to Rs 418.83 crore from Rs 252.82 crore a year earlier. Reported intangible assets and assets under development increased by Rs 129.58 crore, while revenue rose across agrochemicals and non-agrochemicals but consolidated net profit declined Rs 37.41 crore.

The next disclosures will show whether purchases continue at the September 2026 half-year level and how the Rs 303.76 crore of intangible assets under development changes. The filing does not disclose the specific products, registrations, projects, completion dates or capital-spending target represented by the intangible-assets purchase line, leaving those matters unresolved.